肿瘤-间质比是2018 FIGO IIIC期宫颈鳞癌根治术后生存的独立预测因子
多因素分析显示肿瘤≥4 cm、≥3枚转移淋巴结和间质高状态是DFS和OS缩短的独立预测因子,并据此构建预后评分系统(低危0分、中危1分、高危2-3分),对DFS和OS区分度良好(C-index均为0.65,95%CI 0.59-0.72)。
要点
- 肿瘤≥4 cm、≥3枚转移淋巴结和间质高状态是DFS和OS缩短的独立预测因子。
- 基于上述三因素构建的预后评分系统(0/1/2-3分)对DFS和OS区分度良好,C-index均为0.65(95%CI 0.59-0.72)。
核心结论
- TSR是2018 FIGO IIIC期宫颈鳞癌根治术后的独立预后因素,纳入TSR的预后评分系统对复发和生存均有良好区分能力,TSR可能成为预测此类患者预后的新型临床病理变量,尚待验证。
主要发现
- 多因素分析中,肿瘤≥4 cm、≥3枚转移淋巴结和间质高状态是DFS和OS缩短的独立预测因子。
- 将上述因素纳入预后评分系统,患者分为低危(0分)、中危(1分)和高危(2-3分)组,该系统对DFS和OS区分度良好(C-index均为0.65,95%CI 0.59-0.72)。
关键数值与推荐
- TSR分类阈值:间质低为<50%间质,间质高为≥50%间质。
- 预后评分系统分组:低危0分、中危1分、高危2-3分。
- 评分系统区分度:DFS的C-index=0.65(95%CI 0.59-0.72),OS的C-index=0.65(95%CI 0.59-0.72)。
临床怎么用
- 对于2018 FIGO IIIC期宫颈鳞癌根治术后患者,可基于HE染色切片评估TSR,并结合肿瘤大小和转移淋巴结数目进行预后评分分层。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the value of the tumor-stroma ratio (TSR) while identifying prognostic factors in patients with 2018 International Federation of Gynecology and Obstetrics (FIGO) stage IIIC squamous cell carcinoma of the cervix following primary radical surgery. METHODS: Three hundred eighty-four patients with node-positive squamous cell carcinoma of the cervix (2018 FIGO stage IIIC) who underwent radical surgery between January 2005 and December 2016 were included in this retrospective study. The TSRs were assessed on hematoxylin and eosin-stained tumor slides and classified as stroma-low (<50% stroma) or stroma-high (≥50% stroma). RESULTS: Sixty-seven patients were categorized as stroma-high; they had shorter disease-free survival (DFS) and overall survival (OS) periods than did their stroma-low counterparts. On multivariate analysis, a tumor size ≥4 cm, ≥3 metastatic lymph nodes, and stroma-high status were independent predictors of shorter DFS and OS. These factors were incorporated into a prognostic scoring system in which patients were categorized into low- (score 0), intermediate- (score 1), and high-risk (scores 2-3) groups. The scoring system differentiated DFS and OS well (C-index = 0.65, 95% confidence interval, 0.59-0.72; and C-index = 0.65, 95% confidence interval, 0.59-0.72, respectively). CONCLUSIONS: The TSR is an independent prognostic factor, and our prognostic scoring system that incorporates this parameter exhibits good discriminative ability for both recurrence and survival in patients with 2018 FIGO stage IIIC cervical cancer after radical surgery. The TSR is a potentially novel clinicopathological variable for predicting the prognoses of these patients contingent on the validation of our findings.
引用
- Zong L, Zhang Q, Kong Y, et al. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery. Gynecol Oncol. 2019. PMID: 31882242. doi:10.1016/j.ygyno.2019.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。